Agree with everything you said.
I'm still hopeful that these deoxymabs with their patents are worth something.
James said that we don't have enough money to take DX3 to the clinic and that he wants to raise money without dilution. Only 2 ways, borrow money or strike a partnership deal. It's a high quality looking board that now needs to show us shareholders that they are worth their position.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 226590723 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 55843936 | 26 |
View Market Depth
| Last trade - 10.08am 29/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable